Saturday 17 October 2026
Export ACHC’s income statement to Excel — free account
Acadia Healthcare Company, Inc.
ACHC Healthcare Medical Care Facilities
Acadia Healthcare Company, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.3 billion, up 5.04% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS fell 63.6%, free cash flow grew 856.5% and total debt rose 6.49%, each against the same quarter a year earlier. Revenue growth for five consecutive years.
29.98
1.06
−3.41%
Follow ACHC
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
5 | 6 | 3 | 7 | 5 | 6 | 6 | 4 | 4 | 5 |
P/E ratio |
411.13 | 14.76 | 0.00 | 26.58 | 0.00 | 28.36 | 26.80 | 0.00 | 14.16 | 0.00 |
P/S ratio |
1.00 | 1.04 | 1.18 | 1.45 | 2.12 | 2.33 | 2.80 | 2.43 | 1.15 | 0.39 |
Altman Z-Score |
1.22 | 1.22 | 0.89 | 0.93 | 1.24 | 2.20 | 2.94 | 2.48 | 1.67 | 0.92 |
P/FCF ratio |
212.75 | 32.81 | 15.75 | 25.99 | 10.19 | 40.47 | 79.86 | 105.25 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
1.30 | 1.47 | 1.14 | 1.15 | 1.88 | 1.80 | 2.24 | 1.50 | 1.92 | 0.93 |
P/Operating CF |
27.68 | 22.93 | 17.55 | 24.38 | 23.69 | 55.07 | 64.36 | 61.20 | 31.13 | (14.92) |
Beneish M-Score |
(2.53) | (2.50) | (2.46) | (2.51) | (3.18) | (2.29) | (2.42) | (2.88) | (2.38) | (3.58) |
Dividend Safety Score |
— | — | — | — | — | — | — | — | — | 2 |
P/B ratio |
1.30 | 1.14 | 0.96 | 1.16 | 2.33 | 2.14 | 2.60 | 2.56 | 1.18 | 0.66 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 8.28 | 0.00 | 21.78 | 14.22 | 14.74 | 4.92 | 2.32 |
EV/Sales |
2.15 | 2.16 | 2.83 | 2.97 | 3.43 | 2.92 | 3.29 | 2.86 | 1.75 | 1.10 |
EV/EBITDA |
10.24 | 10.35 | 13.59 | 14.40 | 15.13 | 12.85 | 14.60 | 12.93 | 8.16 | 6.28 |
EV/Operating CF |
16.74 | 15.30 | 13.01 | 17.90 | 10.87 | 18.03 | 22.59 | 18.15 | 42.51 | 27.70 |
EV/FCF |
456.60 | 68.22 | 37.80 | 53.22 | 16.51 | 50.70 | 93.94 | 124.05 | (10.02) | (8.78) |
Quick Ratio |
0.93 | 0.97 | 0.89 | 0.84 | 0.50 | 1.03 | 1.08 | 0.52 | 0.76 | 1.09 |
Current Ratio |
1.25 | 1.25 | 1.08 | 1.17 | 1.93 | 1.22 | 1.30 | 0.67 | 1.00 | 1.55 |
Net Debt/EBITDA |
5.47 | 5.37 | 7.93 | 7.37 | 5.79 | 2.60 | 2.19 | 1.96 | 2.78 | 4.07 |
Debt/Assets |
54.57% | 50.43% | 51.74% | 45.78% | 48.04% | 31.40% | 27.78% | 25.60% | 32.85% | 45.23% |
Debt/Equity |
1.52 | 1.26 | 1.37 | 1.26 | 1.64 | 0.59 | 0.49 | 0.49 | 0.64 | 1.28 |
Asset Turnover |
0.55 | 0.46 | 0.30 | 0.31 | 0.31 | 0.41 | 0.54 | 0.57 | 0.56 | 0.58 |
Operating CF/Net income |
58.84 | 2.00 | (2.36) | 3.06 | (0.98) | 1.96 | 1.39 | (21.34) | 0.51 | (0.12) |
Capex/Depreciation |
(2.39) | (2.03) | (2.99) | (2.21) | (2.08) | (2.18) | (2.39) | (2.91) | (4.42) | (2.82) |
Interest Coverage |
2.45 | 2.49 | 1.66 | 1.68 | 2.31 | 5.38 | 6.70 | 6.25 | 4.49 | 2.79 |
| 0.32% | 8.43% | (7.16%) | 4.50% | (30.52%) | 8.63% | 10.25% | (0.77%) | 8.73% | (43.91%) | |
| 0.12% | 3.21% | (2.79%) | 1.67% | (10.05%) | 3.38% | 5.60% | (0.42%) | 4.52% | (19.20%) | |
ROIC |
5.15% | 4.76% | 3.49% | 3.53% | 4.92% | 6.67% | 7.13% | 7.91% | 6.59% | 5.62% |
Return on Tangible Assets |
0.22% | 6.36% | (5.59%) | 6.90% | (23.68%) | 10.24% | 13.20% | (1.10%) | 8.96% | (32.43%) |
Average Days of Receivables |
34.19 | 38.21 | 60.96 | 52.50 | 47.77 | 44.37 | 45.09 | 45.05 | 42.28 | 48.55 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
65.63% | 65.11% | 65.15% | 65.29% | 65.18% | 63.57% | 63.27% | 63.32% | 63.20% | 64.42% |
Intangible Assets out of Total Assets |
0.46 | 0.44 | 0.40 | 0.31 | 0.33 | 0.48 | 0.46 | 0.43 | 0.39 | 0.25 |
Share Based Compensation of Revenue |
1.01% | 0.83% | 1.16% | 0.86% | 1.08% | 1.62% | 1.14% | 1.10% | 1.18% | 0.96% |
Graham Net Nets |
(1.22) | (1.15) | (1.51) | (1.32) | (0.47) | (0.33) | (0.23) | (0.28) | (0.63) | (2.15) |
Graham Number |
6.75 | 39.05 | 0.00 | 28.36 | 0.00 | 36.95 | 46.32 | 0.00 | 45.97 | 0.00 |
Earnings Yield |
0.24% | 6.77% | (7.86%) | 3.76% | (15.20%) | 3.53% | 3.73% | (0.31%) | 7.06% | (85.98%) |
Free Cash Flow Yield |
0.47% | 3.05% | 6.35% | 3.85% | 9.82% | 2.47% | 1.25% | 0.95% | (15.15%) | (32.33%) |
Revenue per Share |
32.80 | 32.62 | 21.82 | 22.92 | 23.78 | 26.07 | 29.11 | 32.20 | 34.42 | 36.52 |
Operating CF per Share |
4.22 | 4.60 | 4.74 | 3.80 | 7.50 | 4.22 | 4.24 | 5.08 | 1.42 | 1.45 |
Capex per Share |
(4.06) | (3.57) | (3.11) | (2.52) | (2.56) | (2.72) | (3.22) | (4.34) | (7.42) | (6.04) |
Free Cash Flow per Share |
0.15 | 1.03 | 1.63 | 1.28 | 4.94 | 1.50 | 1.02 | 0.74 | (6.01) | (4.59) |
Cash per Share |
0.67 | 0.77 | 0.58 | 1.14 | 4.31 | 1.51 | 1.09 | 1.10 | 0.83 | 1.47 |
Shareholders Equity per Share |
25.29 | 29.59 | 26.73 | 28.60 | 21.62 | 28.36 | 31.36 | 30.59 | 33.55 | 21.49 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
25.29 | 29.59 | 26.73 | 28.60 | 21.62 | 28.36 | 31.36 | 30.59 | 33.55 | 21.49 |
Free Cash Flow |
13.25 | 89.60 | 142.51 | 111.99 | 433.94 | 133.16 | 91.49 | 67.63 | (550.26) | (416.06) |
Working Capital |
85.06 | 94.16 | 34.04 | 78.64 | 1,215.21 | 90.17 | 117.80 | (289.78) | (0.43) | 288.95 |
Capital Expenditures |
(348.23) | (309.98) | (271.57) | (220.91) | (224.87) | (241.32) | (289.07) | (394.71) | (679.95) | (547.96) |
Net Current Asset Value |
(3,429.07) | (3,380.08) | (3,388.78) | (3,831.55) | (2,076.51) | (1,755.56) | (1,669.05) | (1,980.87) | (2,305.71) | (2,764.35) |
EV/EBIT |
13.59 | 13.96 | 17.63 | 18.98 | 19.60 | 16.29 | 18.38 | 16.35 | 10.56 | 9.42 |
Capex to Sales |
0.12 | 0.11 | 0.14 | 0.11 | 0.11 | 0.10 | 0.11 | 0.13 | 0.22 | 0.17 |
Price to Operating Income |
6.33 | 6.71 | 7.35 | 9.27 | 12.09 | 13.00 | 15.62 | 13.87 | 6.96 | 3.32 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.05 | 0.05 | 0.03 | 0.07 | 0.07 | 0.06 | 0.06 | 0.06 | 0.05 | 0.06 |
Cash ROIC |
0.24% | 1.52% | 2.56% | 1.95% | 8.03% | 3.21% | 2.13% | 1.59% | (10.77%) | (9.08%) |
Accounts Receivable Turnover |
11.71 | 10.13 | 6.19 | 6.62 | 7.43 | 8.34 | 8.65 | 8.56 | 8.68 | 8.22 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
0.84 | 0.83 | 0.77 | 0.93 | 1.11 | 1.02 | 0.91 | — | — | — |
Average Receivables |
239.98 | 280.13 | 307.51 | 303.48 | 281.21 | 277.44 | 301.89 | 341.95 | 363.40 | 402.97 |
Average Payables |
85.69 | 91.17 | 110.02 | 104.00 | 89.04 | 93.20 | 101.65 | 130.43 | 194.42 | 191.55 |
Average Inventory |
5.00 | 5.00 | 5.00 | 4.50 | 4.50 | 5.00 | 5.00 | — | — | — |
Average Assets |
5,151.97 | 6,224.61 | 6,298.50 | 6,525.82 | 6,689.25 | 5,633.72 | 4,877.99 | 5,173.37 | 5,657.88 | 5,742.18 |
Average Common Equity |
1,925.38 | 2,370.30 | 2,453.09 | 2,419.34 | 2,202.42 | 2,208.47 | 2,665.11 | 2,797.35 | 2,927.84 | 2,511.34 |
Columns are period end dates